Venture Certified
| 혁신성장유형 | 2023-08-09 ~ 2026-08-08 | 20230809030019 | 2023-08-09 |
Revenue CAGR +424.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.2B | 0.0B | 0.0B |
| Operating Profit | -1.8B | -1.5B | -0.6B |
| Net Profit | 0.0B | -0.0B | -0.3B |
| Total Assets | 2.7B | 1.7B | 0.2B |
| Total Liabilities | 1.0B | 1.0B | 0.5B |
| Total Equity | 1.7B | 0.6B | -0.2B |
Operating Loss: Op. profit -2B
▲ 949.6%
▼ 74.5%
▲ 77.3%
▲ 332.5%
▼ 99.4%
| Name | Position | Role |
|---|---|---|
| 조찬희 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 화성시",
"ceo_name": "조찬희",
"certificate": [
{
"cert_number": "20230809030019",
"changes": "소재지",
"disclosure_date": "2023-08-09",
"first_cert_date": "2023-08-09",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2023-08-09 ~ 2026-08-08"
}
],
"company_name": "(주)에피큐어",
"corp_no": "135811-*******",
"financials": {
"2022": {
"capital_stock": 10000000,
"cost_of_sales": 0,
"current_assets": 15391000,
"current_liabilities": 46822000,
"gross_profit": 0,
"net_income": -31980000,
"net_income_bs": -31980000,
"non_current_assets": 9435000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 23956000,
"operating_profit": -55936000,
"revenue": 0,
"sga_expenses": 55936000,
"total_assets": 24826000,
"total_equity": -21996000,
"total_liabilities": 46822000
},
"2023": {
"capital_stock": 100000000,
"cost_of_sales": 3116000,
"current_assets": 102665000,
"current_liabilities": 2409000,
"gross_profit": -179000,
"net_income": -3598000,
"net_income_bs": -3598000,
"non_current_assets": 64150000,
"non_current_liabilities": 100000000,
"non_operating_expenses": 1964000,
"non_operating_income": 151830000,
"operating_profit": -153464000,
"revenue": 2937000,
"sga_expenses": 153285000,
"total_assets": 166815000,
"total_equity": 64406000,
"total_liabilities": 102409000
},
"2024": {
"capital_stock": 200000000,
"cost_of_sales": 59208000,
"current_assets": 103733000,
"current_liabilities": 3388000,
"gross_profit": -43794000,
"net_income": 722000,
"net_income_bs": 713000,
"non_current_assets": 164774000,
"non_current_liabilities": 100000000,
"non_operating_expenses": 4271000,
"non_operating_income": 187671000,
"operating_profit": -182678000,
"revenue": 15414000,
"sga_expenses": 138884000,
"total_assets": 268507000,
"total_equity": 165119000,
"total_liabilities": 103388000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "치매의약품 후보물질",
"phone": "010-2221-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |